Skysona is a Intravenous Suspension in the Cellular Therapy category. It is labeled and distributed by Bluebird Bio, Inc.. The primary component is Elivaldogene Autotemcel.
Product ID | 73554-2111_22fb6d79-4f85-46ef-9ff2-443a74a38f27 |
NDC | 73554-2111 |
Product Type | Cellular Therapy |
Proprietary Name | Skysona |
Generic Name | Elivaldogene Autotemcel |
Dosage Form | Suspension |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2022-09-16 |
Marketing Category | BLA / |
Application Number | BLA125755 |
Labeler Name | bluebird bio, Inc. |
Substance Name | ELIVALDOGENE AUTOTEMCEL |
Active Ingredient Strength | 30000000 1/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-09-16 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SKYSONA 98301155 not registered Live/Pending |
bluebird bio, Inc. 2023-12-06 |
SKYSONA 98301147 not registered Live/Pending |
bluebird bio, Inc. 2023-12-06 |
SKYSONA 98301127 not registered Live/Pending |
bluebird bio, Inc. 2023-12-06 |
SKYSONA 97229976 not registered Live/Pending |
bluebird bio, Inc. 2022-01-20 |
SKYSONA 97229967 not registered Live/Pending |
bluebird bio, Inc. 2022-01-20 |
SKYSONA 97229964 not registered Live/Pending |
bluebird bio, Inc. 2022-01-20 |
SKYSONA 97138015 not registered Live/Pending |
bluebird bio, Inc. 2021-11-22 |
SKYSONA 97132256 not registered Live/Pending |
bluebird bio, Inc. 2021-11-18 |
SKYSONA 79324824 not registered Live/Pending |
Bluebird Bio (UK) Ltd 2021-03-08 |
SKYSONA 79219837 5516212 Live/Registered |
BLUEBIRD BIO, INC. 2017-08-15 |